Home/ Stocks/ LIVN

LivaNova PLC Ordinary Shares

LIVN XNAS

$71.86 +0.94 (+1.32%) ▲ 15-min delayed

Open

$71.25

High

$72.51

Low

$70.32

Volume

921.1K

Market Cap

$3.95B

About LivaNova PLC Ordinary Shares

UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Sector: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS Employees: 3.3K Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$362.26M	$22.29M	$0.41
FY 2025	$1.39B	$-242,471,000	$-4.45
Q3 2025	$357.75M	$26.78M	$0.49
Q2 2025	$352.52M	$27.16M	$0.50

Earnings & Analyst Ratings

Next Earnings: Tue, Aug 4, 2026

Calendar →

Related Market News

No specific coverage for LIVN yet. Check out our latest market news or earnings calendar.

Get LIVN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on LivaNova PLC Ordinary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.